ACTIVE

PHARMADEC

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

103,7 k €

-3.8% YoY

Gross margin

130,3 k €

-11.0% YoY

Equity

1,2 M €

-2.1% YoY

Workforce

1,1 ETP

What does PHARMADEC do?

PHARMADEC is a Public limited company incorporated in 1989. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Westerlo. It employs on average 1,1 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0439.401.882

Incorporation

27/12/1989

Legal form

Public limited company

Registered office

Pastoor Binckstraat 11
2260 Westerlo · FlandreSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

1,1 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	130,3 k €	-11.0%	146,4 k €	-14.5%	171,2 k €	+5.1%	162,9 k €	+10.2%	147,8 k €	+1.9%	144,9 k €	-15.3%	171,1 k €	+52.3%	112,3 k €	-13.4%	129,7 k €	-3.7%	134,7 k €	+6.9%	126 k €	+31.0%	96,2 k €	-38.0%	155,2 k €	+37.1%	113,2 k €	-3.0%	116,6 k €	+1.3%	115,1 k €	+7.8%	106,8 k €	+2.2%	104,5 k €	+166%	39,2 k €	+70.7%	23 k €
EBITDA	72,2 k €	-50.3%	145,2 k €	-10.0%	161,4 k €	+5.4%	153,1 k €	+10.9%	138 k €	+1.9%	135,4 k €	-15.2%	159,7 k €	+58.4%	100,8 k €	-15.0%	118,6 k €	-4.4%	124 k €	+6.1%	116,8 k €	+32.5%	88,2 k €	-38.5%	143,5 k €	+39.2%	103,1 k €	+0.3%	102,8 k €	-2.2%	105,1 k €	+8.3%	97 k €	+0.5%	96,6 k €	+208%	31,3 k €	+187%	10,9 k €
Operating result	70,5 k €	-51.5%	145,2 k €	-10.0%	161,4 k €	+5.4%	153,1 k €	+11.5%	137,3 k €	+3.6%	132,6 k €	-15.1%	156,2 k €	+60.7%	97,2 k €	-15.1%	114,5 k €	-4.6%	120 k €	+8.9%	110,2 k €	+34.7%	81,8 k €	-40.3%	137 k €	+41.2%	97 k €	+0.3%	96,8 k €	-5.8%	102,7 k €	+9.6%	93,7 k €	+1.6%	92,2 k €	+269%	25 k €	+391%	5,1 k €
Net result	103,7 k €	-3.8%	107,9 k €	-13.8%	125,1 k €	+2.5%	122,1 k €	+9.6%	111,4 k €	+2.9%	108,3 k €	-14.5%	126,6 k €	+56.3%	81 k €	-5.7%	85,8 k €	-7.5%	92,8 k €	+3.1%	90 k €	+11.7%	80,6 k €	-30.5%	116 k €	+33.5%	86,9 k €	-1.3%	88,1 k €	-2.3%	90,1 k €	+4.6%	86,2 k €	+0.1%	86,1 k €	+120%	39,1 k €	+116%	18,1 k €
Balance sheet
Equity	1,2 M €	-2.1%	1,2 M €	+9.5%	1,1 M €	+12.3%	1 M €	+13.8%	884,6 k €	+14.4%	773,2 k €	+16.3%	664,9 k €	+23.5%	538,3 k €	-49.0%	1,1 M €	+8.9%	970 k €	+10.6%	877,2 k €	+0.6%	872,1 k €	+1.2%	861,5 k €	+5.6%	816,1 k €	+11.3%	733,2 k €	+12.9%	649,2 k €	+15.3%	563,1 k €	+17.1%	480,9 k €	+20.6%	398,8 k €	+9.6%	363,8 k €
Total assets	1,4 M €	+7.7%	1,3 M €	+9.8%	1,2 M €	+2.3%	1,2 M €	+13.5%	1 M €	+12.2%	922,7 k €	+15.4%	799,9 k €	+23.7%	646,8 k €	-44.3%	1,2 M €	+5.0%	1,1 M €	+1.1%	1,1 M €	+0.5%	1,1 M €	+7.3%	1 M €	+7.8%	940,7 k €	+7.6%	874 k €	+6.6%	819,5 k €	+21.3%	675,5 k €	+16.8%	578,4 k €	+17.7%	491,4 k €	+9.3%	449,5 k €
Cash	110,4 k €	-89.2%	1 M €	+13.7%	901,9 k €	-0.2%	903,9 k €	+20.5%	750,3 k €	+16.9%	641,8 k €	+22.1%	525,5 k €	+33.4%	394 k €	-31.6%	576 k €	+18.1%	487,6 k €	+1.5%	480,5 k €	+4.4%	460,3 k €	-39.0%	755,1 k €	+7.4%	702,9 k €	+16.4%	604,1 k €	+5.3%	573,6 k €	+31.2%	437,2 k €	+24.5%	351,1 k €	+28.6%	273 k €	+16.7%	233,9 k €
Debts	204,2 k €	+161%	78,3 k €	+10.0%	71,1 k €	-57.2%	166 k €	+10.4%	150,4 k €	+0.9%	149,1 k €	+10.7%	134,7 k €	+24.6%	108,1 k €	+3.5%	104,4 k €	-22.7%	135,1 k €	-37.5%	216,3 k €	+0.3%	215,7 k €	+42.6%	151,3 k €	+23.6%	122,4 k €	-12.5%	139,8 k €	-17.3%	169,1 k €	+51.8%	111,4 k €	+15.7%	96,3 k €	+7.5%	89,6 k €	+5.7%	84,8 k €
Other
Workforce	1,1 ETP		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 16 ended

Active mandates

Juvidra

Director · since 01 mars 2025 · 1019.008.061

Represented by Verbanck Tine

Active

Ended mandates

Juvidra

Director · since 01 mars 2025 · 1019.008.061

Represented by Verbanck TINE

Ended

JORIS DE CEUSTER

Director · since 05 juin 2015 · until 05 juin 2021

Ended

LUDOVICA SMETS

Director · since 05 juin 2015 · until 05 juin 2021

Ended

MARCEL DE CEUSTER

Managing director · since 05 juin 2015 · until 05 juin 2021

Ended

At this address

Other companies at this address

Company	CBE no.
MEDEC● Active	0462.382.271

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/06/2026	10/06/2025	02/07/2024	30/08/2023	22/09/2022	29/08/2021
General meeting	05/06/2026	06/06/2025	07/06/2024	02/06/2023	03/06/2022	04/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	05/06/2026	19/06/2026	Dutch	PDF
Abridged model	31/12/2024	06/06/2025	10/06/2025	Dutch	PDF
Abridged model	31/12/2023	07/06/2024	02/07/2024	Dutch	PDF
Abridged model	31/12/2022	02/06/2023	30/08/2023	Dutch	PDF
Abridged model	31/12/2021	03/06/2022	22/09/2022	Dutch	PDF
Abridged model	31/12/2020	04/06/2021	29/08/2021	Dutch	PDF
Abridged model	31/12/2019	05/06/2020	22/07/2020	Dutch	PDF
Abridged model	31/12/2018	07/06/2019	26/08/2019	Dutch	PDF
Abridged model	31/12/2017	01/06/2018	02/07/2018	Dutch	PDF
Abridged model	31/12/2016	02/06/2017	30/06/2017	Dutch	PDF
Abridged model	31/12/2015	03/06/2016	29/06/2016	Dutch	PDF
Abridged model	31/12/2014	05/06/2015	02/07/2015	Dutch	PDF
Abridged model	31/12/2013	06/06/2014	02/07/2014	Dutch	PDF
Abridged model	31/12/2012	07/06/2013	04/07/2013	Dutch	PDF
Abridged model	31/12/2011	01/06/2012	29/06/2012	Dutch	PDF
Abridged model	31/12/2010	03/06/2011	30/06/2011	Dutch	PDF
Abridged model	31/12/2009	04/06/2010	30/06/2010	Dutch	PDF
Abridged model	31/12/2008	05/06/2009	01/07/2009	Dutch	PDF
Abridged model	31/12/2007	06/06/2008	01/07/2008	Dutch	PDF
Abridged model	31/12/2006	01/06/2007	21/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 16 ended

Active mandates

Juvidra

Director · since 01 mars 2025 · 1019.008.061

Represented by Verbanck Tine

Active

Ended mandates

Juvidra

Director · since 01 mars 2025 · 1019.008.061

Represented by Verbanck TINE

Ended

JORIS DE CEUSTER

Director · since 05 juin 2015 · until 05 juin 2021

Ended

LUDOVICA SMETS

Director · since 05 juin 2015 · until 05 juin 2021

Ended

MARCEL DE CEUSTER

Managing director · since 05 juin 2015 · until 05 juin 2021

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates18/03/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/10/2023
ONTSLAGEN - BENOEMINGEN
PDF
Registered office03/12/2018
MAATSCHAPPELIJKE ZETEL
PDF
Capital / shares20/02/2018
KAPITAAL - AANDELEN
PDF
Mandates27/10/2016
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares20/01/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates21/09/2009
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/04/2003
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025103,7 k €↓
2024
Annual accounts 2024107,9 k €↓
2023
Annual accounts 2023125,1 k €↑
2022
Annual accounts 2022122,1 k €↑
2021
Annual accounts 2021111,4 k €↑
2020
Annual accounts 2020108,3 k €↓
2019
Annual accounts 2019126,6 k €↑
2018
Annual accounts 201881 k €↓
2017
Annual accounts 201785,8 k €↓
2016
Annual accounts 201692,8 k €↑
2015
Annual accounts 201590 k €↑
2014
Annual accounts 201480,6 k €↓
2013
Annual accounts 2013116 k €↑
2012
Annual accounts 201286,9 k €↓
2011
Annual accounts 201188,1 k €↓
2010
Annual accounts 201090,1 k €↑
2009
Annual accounts 200986,2 k €↑
2008
Annual accounts 200886,1 k €↑
2007
Annual accounts 200739,1 k €↑
2006
Annual accounts 200618,1 k €
27/12/1989
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMADEC

Overview

What does PHARMADEC do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline